JHP Pharmaceuticals to Produce Lyophilized Biologic for International Late-Phase Clinical Trials

JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile products, has entered into an agreement with an undisclosed pharmaceutical company to produce supplies of a lyophilized biologic for international, late-phase clinical trials.
MarketWatch